Cancer Biology Research (93.396)
Cancer Biology Research (Assistance Listing 93.396) is run by the National Institutes of Health, part of the Department of Health and Human Services. It awarded $4.3 billion in 3,142 grants from fiscal 2021 to 2025, about $1.4 million per award on average. 35 funding opportunities are open or forecast now.
The typical award was $1.2 million. Half of the 3,142 awards fell between $498,000 and $1.8 million, and they ranged from $0 to $17.4 million.
- Awarded, FY 2021 to 2025$4.3 billion
- Grant awards3,142
- Typical award$1.2 million
- Awarded in FY 2025$914 million
- Size rank103 of 1824
- Type of assistanceCooperative agreements, project grants
Key findings
- Annual funding rose from $795 million in fiscal 2021 to $914 million in fiscal 2025.
- It is the 103rd largest of 1,824 federal grant programs by five-year awards.
- The 20 largest recipients received 40% of the money.
- Awards went to recipients in 50 states and territories.
What the program funds
To provide fundamental information on the cause and nature of cancer in people, with the expectation that this will result in better methods of prevention, detection and diagnosis, and treatment of neoplastic diseases. Cancer Biology Research includes the following research programs: cancer cell biology; cancer immunology, hematology and etiology; DNA and chromosomal aberrations; tumor biology and metastasis; and structural biology and molecular applications.
Open opportunities
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
Rules from the program listing
Who can apply
The awardee will be a university, college, hospital, public agency, nonprofit research institution or for-profit organization that submits an application and receives a grant for support of research by a named principal investigator. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
What the money can and cannot pay for
Grants and cooperative agreements may be made to eligible institutions for the support of cancer research projects. The grants and cooperative agreements may be used for personnel, consultant costs, equipment, supplies, travel, patient costs, animals, alterations and renovations, miscellaneous items, and Facilities and Administrative Costs (formerly known as indirect costs).
Matching requirements
This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.
Deadlines
All Grants including renewals and supplements: April 5, August 5, December 5. Cooperative Agreements and contracts are usually submitted in response to a Request for Applications (RFA) or a Request for Proposals (RFP). The receipt date is stipulated in the RFA or RFP. Note that for New Investigator and Early Stage Investigators applying for an R01 resubmission there are expedited review dates described in NOT-OD-11-057 (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-057.html).
Award range and average, in the agency's words
Range: $4,800 to $3,144,604 Average: $490,440
Funding history and past recipients
From fiscal 2021 to 2025, Cancer Biology Research (93.396) awarded$4.3 billion across 3,142 grant awards, an average of $1.4 million per award.
Who usually wins
Colleges and universities received 69% of the money, nonprofits 27% and small businesses 1.1%.
| Recipient type | Awards | Amount | Share |
|---|---|---|---|
| Colleges and universities | 2,190 | $3.0 billion | 69% |
| Nonprofits | 771 | $1.1 billion | 27% |
| Other | 121 | $153 million | 3.6% |
| Small businesses | 54 | $48.9 million | 1.1% |
| State and local governments | 5 | $2.3 million | less than 0.1% |
| Businesses | 1 | $2.3 million | less than 0.1% |
By state
45 states have a page for this program: those that received at least $1 million or 10 awards.
| State | Awards | Amount |
|---|---|---|
| New York | 427 | $715 million |
| California | 409 | $607 million |
| Massachusetts | 263 | $409 million |
| Texas | 294 | $370 million |
| Pennsylvania | 218 | $286 million |
| Florida | 112 | $165 million |
| Ohio | 126 | $154 million |
| North Carolina | 105 | $141 million |
| Illinois | 117 | $130 million |
| Tennessee | 52 | $117 million |
| Washington | 74 | $108 million |
| Michigan | 78 | $104 million |
| Missouri | 60 | $91.7 million |
| Maryland | 91 | $77.7 million |
| Connecticut | 51 | $73.8 million |
| Wisconsin | 51 | $70.3 million |
| Minnesota | 47 | $62.1 million |
| New Jersey | 47 | $55.8 million |
| Georgia | 42 | $55.6 million |
| Virginia | 47 | $51.0 million |
| Indiana | 39 | $47.8 million |
| Oregon | 30 | $44.7 million |
| Colorado | 48 | $40.4 million |
| South Carolina | 26 | $33.1 million |
| Alabama | 33 | $33.0 million |
| Arizona | 19 | $31.1 million |
| District of Columbia | 23 | $27.7 million |
| Utah | 28 | $26.6 million |
| Kentucky | 25 | $24.5 million |
| Louisiana | 23 | $22.1 million |
| Nebraska | 17 | $18.3 million |
| Maine | 10 | $15.5 million |
| New Hampshire | 10 | $15.4 million |
| Oklahoma | 17 | $12.3 million |
| Iowa | 6 | $9.7 million |
| Rhode Island | 28 | $7.5 million |
| Arkansas | 7 | $6.6 million |
| Hawaii | 3 | $5.6 million |
| Puerto Rico | 5 | $5.0 million |
| Kansas | 4 | $4.0 million |
| Delaware | 3 | $2.7 million |
| Vermont | 4 | $2.6 million |
| New Mexico | 5 | $1.9 million |
| Nevada | 2 | $1.6 million |
| Montana | 2 | $1.1 million |
| North Dakota | 2 | $937,353 |
| Mississippi | 1 | $703,448 |
| Idaho | 1 | $423,689 |
| South Dakota | 1 | $413,479 |
| West Virginia | 1 | $44,048 |